AKR1C2 and neoplasm: For the orthotopic xenograft model, the metastatic tumor cells, particularly the liver and bone cells, possessed significantly higher expression levels of AKR1C1, AKR1C2 and AKR1C3 (Figs 3c and 5b), corresponding with increased cisplatin resistance (Fig. 5c,d).